The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Novel non-invasive method for measuring intracranial pressure for drug delivery and other neurologic disorders.
 
Priya Kumthekar
Consulting or Advisory Role - Affinia Therapeutics; Belay Diagnostics; Biocept; BioClinica; Biodexa; BPGbio; EnClear Therapies; IN8bio; Novocure; Plus Therapeutics; SDP Oncology; SERVIER; Telix Pharmaceuticals
Speakers' Bureau - Seagen
Research Funding - Angiochem; DNAtrix; Genentech; Novocure; Orbus Therapeutics
Patents, Royalties, Other Intellectual Property - Utility patent for ANG 1005. No financial gain, no royalties.
 
Margaret Schwartz
Consulting or Advisory Role - EnClear Therapies
Speakers' Bureau - Novocure
Other Relationship - Novocure
 
Seema Nagpal
Consulting or Advisory Role - Biocept; EnClear Therapies; Mirati Therapeutics; Novocure; Nurix; Pyramid Biosciences; SERVIER; Telix Pharmaceuticals
Research Funding - ABM (Inst); Berg Pharma (Inst); Novocure (Inst); SERVIER (Inst); VBI Vaccines (Inst)
 
Isabella Claudia Glitza
Honoraria - Amgen
Consulting or Advisory Role - Array BioPharma; Bristol-Myers Squibb; Leal Therapeutics; Midatech Pharma; Novartis; Sintetica
Speakers' Bureau - Array BioPharma
Research Funding - Bristol-Myers Squibb (Inst); Merck (Inst); Pfizer (Inst)
 
Peter A. J. Forsyth
Honoraria - Abbvie; BTG; Novocure; Stanford University Health, Department of Neurology
Consulting or Advisory Role - Abbvie; Boehringer Ingelheim; Boehringer Ingelheim; Bristol-Myers Squibb; BTG; Midatech Pharma; National Brain Tumor Society; Novartis; Novocure; Tocagen; ZIOPHARM Oncology
Research Funding - Bankhead-Coley Cancer Research; Bristol-Myers Squibb; Department of Defense; Florida Academic Cancer Center Alliance; Florida Breast Cancer Foundation; MSCCoE; NIH/NCI; Pfizer
Travel, Accommodations, Expenses - Abbvie; Bayer; Bristol-Myers Squibb; BTG; Inovio Pharmaceuticals; National Cancer Research Institute (NCRI); NCCN; NCI; NIH; Physical Sciences Oncology Network
 
William Gormley
(OPTIONAL) Uncompensated Relationships - EnClear Therapies; Zeta
 
Rajan Patel
Employment - EnClear Therapies; Medtronic
Stock and Other Ownership Interests - EnClear Therapies; Medtronic
Patents, Royalties, Other Intellectual Property - EnClear Therapies
 
Marcie Glicksman
Employment - EnClear Therapies
Leadership - EnClear Therapies
Stock and Other Ownership Interests - EnClear Therapies
Consulting or Advisory Role - 1910 Genetics
Patents, Royalties, Other Intellectual Property - EnClear Therapies; Seaport Diagnostics
 
Adam M. Sonabend
Honoraria - Teladoc
Consulting or Advisory Role - CarThera; EnClear Therapies
Research Funding - Agenus
Patents, Royalties, Other Intellectual Property - I am a co-author on patents filed by Northwestern University related to novel treatments for brain tumors. No licensing or financial benefit so far. (Inst)
Other Relationship - Carthera (Inst); Celgene/Bristol-Myers Squibb (Inst)